Novel UBA Domain Mutations of SQSTM1 in Paget's Disease of Bone: Genotype Phenotype Correlation, Functional Analysis, and Structural Consequences
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Three novel missense mutations of SQSTM1 were identified in familial PDB, all affecting the UBA domain. Functional and structural analysis showed that disease severity was related to the type of mutation but was unrelated to the polyubiquitin-binding properties of the mutant UBA domain peptides. Introduction: Mutations affecting the ubiquitin-associated (UBA) domain of Sequestosome 1 (SQSTM1) gene have recently been identified as a common cause of familial Paget's disease of bone (PDB), but the mechanisms responsible are unclear. We identified three novel SQSTM1 mutations in PDB, conducted functional and structural analyses of all PDB-causing mutations, and studied the relationship between genotype and phenotype. Materials and Methods: Mutation screening of the SQSTM1 gene was conducted in 70 kindreds with familial PDB. We characterized the effect of the mutations on structure of the UBA domain by protein NMR, studied the effects of the mutant UBA domains on ubiquitin binding, and looked at genotype-phenotype correlations. Results and Conclusions: Three novel missense mutations affecting the SQSTM1 UBA domain were identified, including a missense mutation at codon 411 (G411S), a missense mutation at codon 404 (M404V), and a missense mutation at codon 425 (G425R). We also identified a deletion leading to a premature stop codon at 394 (L394X). None of the mutations were found in controls. Structural analysis showed that M404V and G425R involved residues on the hydrophobic surface patch implicated in ubiquitin binding, and consistent with this, the G425R and M404V mutants abolished the ability of mutant UBA domains to bind polyubiquitin chains. In contrast, the G411S and P392L mutants bound polyubiquitin chains normally. Genotype-phenotype analysis showed that patients with truncating mutations had more extensive PDB than those with missense mutations (bones involved = 6.05 ± 2.71 versus 3.45 ± 2.46; p < 0.0001). This work confirms the importance of UBA domain mutations of SQSTM1 as a cause of PDB but shows that there is no correlation between the ubiquitin-binding properties of the different mutant UBA domains and disease occurrence or extent. This indicates that the mechanism of action most probably involves an interaction between SQSTM1 and a hitherto unidentified protein that modulates bone turnover.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [401]
Citations
Cites
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
Laurin, N., Brown, J. P., Morissette, J., & Raymond, V. (2002) · The American Journal of Human Genetics · doi:10.1086/340731 · Cited by 563 · cited 4×
“While PDB is genetically heterogeneous,((5,7,8,16)) recent studies have shown that mutations affecting the UBA domain of SQSTM1 are an important cause of the disease.((10,11)) A recurrent proline-leucine mutation affecting codon 392 in the UBA domain of SQSTM1 (P392L) was first identified as a cause of PDB by Laurin e…”
BackgroundInfluentialIncidence and Natural History of Paget's Disease of Bone in England and Wales
Van Staa, T. P., Selby, P., Leufkens, H. G. M., Lyles, K., Sprafka, J. M., & Prof. Cooper, C. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.3.465 · Cited by 369 · cited 3×
“1% individuals over 55 years of age in the United Kingdom.((1)) The cause of PDB is incompletely understood, but genetic factors play an important role, reflected by the fact that between 15% and”
BackgroundInfluentialDomain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget’s disease.
Hocking, L. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.22.2735 · Cited by 350 · cited 7×
“A recurrent mutation affecting codon 392 (P392L) in the ubiquitin-associated (UBA) domain in the Sequestosome 1 (SQSTM1) gene was recently identified as a common cause of familial and sporadic PDB in the French-Canadian population,((10)) and subsequently, we identified this and two other truncating mutations affecting…”
BackgroundMethodSelf-citationFamilial aggregation of paget's disease of bone
Siris, E. S., Ottman, R., Flaster, E., & Kelsey, J. L. (1991) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650060511 · Cited by 218
Familial Aggregation of Paget's Disease of Bone
Siris, E. S., Ottman, R., Flaster, E., & Kelsey, J. L. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.3.541 · Cited by 187 · cited 1×
“40% of affected individuals have at least one affected firstdegree relative.((2,3)) Numerous extended families have been”
BackgroundMueller, T. D., & Feigon, J. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00302-9 · Cited by 184 · cited 1×
“M404 is found in the loop between helices 1 and 2 and forms part of the hydrophobic patch previously implicated in ubiquitin-binding by other UBA domains.((15)) G411 is in the same loop at the N terminus of helix 2.”
BackgroundGenetic Linkage of Paget Disease of the Bone to Chromosome 18q
Cody, J. D., Singer, F. R., Roodman, G. D., Otterund, B., Lewis, T. B., Leppert, M., & Leach, R. J. (1997) · The American Journal of Human Genetics · doi:10.1086/301601 · Cited by 151
Haslam, S. I., Van Hul, W., Morales-Piga, A., Balemans, W., San-Millan, J. L., Nakatsuka, K., Willems, P., Haites, N. E., & Ralston, S. H. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.911 · Cited by 139 · cited 1×
“While PDB is genetically heterogeneous,((5,7,8,16)) recent studies have shown that mutations affecting the UBA domain of SQSTM1 are an important cause of the disease.”
BackgroundSelf-citationPaget Disease of Bone: Mapping of Two Loci at 5q35-qter and 5q31
Laurin, N., Brown, J. P., Lemainque, A., Duchesne, A., Huot, D., Lacourcière, Y., Drapeau, G., Verreault, J., Raymond, V., & Morissette, J. (2001) · The American Journal of Human Genetics · doi:10.1086/322975 · Cited by 139 · cited 2×
“While PDB is genetically heterogeneous,((5,7,8,16)) recent studies have shown that mutations affecting the UBA domain of SQSTM1 are an important cause of the disease.”
BackgroundA family study of Paget's disease of bone.
Sofaer, J. A., Holloway, S. M., & Emery, A. E. (1983) · Journal of Epidemiology and Community Health · doi:10.1136/jech.37.3.226 · Cited by 133 · cited 1×
“40% of affected individuals have at least one affected firstdegree relative.((2,3)) Numerous extended families have been”
Background
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
An overview of the regulation of bone remodelling at the cellular level
Kular, J., Tickner, J., Chim, S. M., & Xu, J. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.03.021 · Cited by 534
“Other mutations have since been identified in the SQSTM1/p62 gene including mutations that result in the complete deletion of the ubiquitin binding domain of p62 [159,160].”
BackgroundRoodman, G. D., & Windle, J. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24281 · Cited by 340
“Patients with truncation mutations in p62 exhibit a more severe Paget phenotype than patients with any of the point mutations (72, 76).”
BackgroundTanaka, S., Nakamura, K., Takahasi, N., & Suda, T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00327.x · Cited by 320
Pathogenesis and management of Paget's disease of bone
Ralston, S. H., Langston, A. L., & Reid, I. R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61035-1 · Cited by 260
Self-citationWooten, M. W., Geetha, T., Seibenhener, M. L., Babu, J. R., Diaz-Meco, M. T., & Moscat, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500237200 · Cited by 225
Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline
Ralston, S. H., Corral-Gudino, L., Cooper, C., Francis, R. M., Fraser, W. D., Gennari, L., Guañabens, N., Javaid, M. K., Layfield, R., O'Neill, T. W., et al. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3657 · Cited by 225
“Mutations in SQSMT1 have been identified in 40% to 50% of familial cases and in 5% to 10% of patients who do not report having a family history.((9,14,15)) Most of the causal mutations impair the ability of p62 to bind ubiquitin, and this leads to activation of receptor activator of nuclear kappa B ligand (RANKL)-indu…”
BackgroundSelf-citationOsteosarcoma in Paget's Disease of Bone
Hansen, M. F., Seton, M., & Merchant, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s211 · Cited by 212
Pathogenesis of Paget Disease of Bone
Ralston, S. H., & Layfield, R. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9599-0 · Cited by 169
Self-citationLong, J., Gallagher, T. R. A., Cavey, J. R., Sheppard, P. W., Ralston, S. H., Layfield, R., & Searle, M. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704973200 · Cited by 157
Self-citationSequestosome 1: Mutation Frequencies, Haplotypes, and Phenotypes in Familial Paget's Disease of Bone
Morissette, J., Laurin, N., & Brown, J. P. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s207 · Cited by 152
“Mutations in SQSTM1/p62 have been observed to segregate in some multiethnic pedigrees; however, they all reported history of at least some white ancestry.((32))”
BackgroundAutophagy: A new player in skeletal maintenance?
Hocking, L. J., Whitehouse, C., & Helfrich, M. H. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1668 · Cited by 143
“A common feature of the bone phenotype that occurs when autophagy components are mutated((33,36,79)) or knocked out((71)) is”
BackgroundSelf-citationDaroszewska, A., van 't Hof, R. J., Rojas, J. A., Layfield, R., Landao-Basonga, E., Rose, L., Rose, K., & Ralston, S. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr172 · Cited by 131
“The penetrance of PDB in SQSTM1 mutation carriers increases with age to reach 80% by the seventh decade (6,14,15).”
BackgroundSelf-citationRea, S. L., Walsh, J. P., Layfield, R., Ratajczak, T., & Xu, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1034 · Cited by 123
“Curiously, 3 of the 14 SQSTM1/p62 mutations (namely P392L, G411S, and G425R) reported in ALS patients (95) have also been identified in patients with PDB.”
BackgroundInfluentialSelf-citationLoss of Ubiquitin-Binding Associated With Paget's Disease of Bone p62 (SQSTM1) Mutations
Cavey, J. R., Ralston, S. H., Hocking, L. J., Sheppard, P. W., Ciani, B., Searle, M. S., & Layfield, R. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041205 · Cited by 116
“Because the normal function of UBA domains is to mediate noncovalent interactions with ubiquitin,((19)) we have previously studied the ubiquitin-binding properties of the isolated p62 UBA domain and found that PDB-causing missense mutations resolved into those which impaired (M404V and G425R) or did not affect (P392L…”
BackgroundMethodResultSelf-citationRolland, P., Madjd, Z., Durrant, L., Ellis, I. O., Layfield, R., & Spendlove, I. (2007) · Endocrine-Related Cancer · doi:10.1677/erc.1.01312 · Cited by 115
“The expression of p62 correlates with the expression of members of the EGF family, particularly HER3 and HER4 and may represent a marker of activation of the NFkB pathway.”
BackgroundSelf-citationDose Effects of Propranolol on Cancellous and Cortical Bone in Ovariectomized Adult Rats
Bonnet, N., Laroche, N., Vico, L., Dolleans, E., Benhamou, C. L., & Courteix, D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105437 · Cited by 121
Pathogenesis of Paget's disease of bone
Ralston, S. H. (2008) · Bone · doi:10.1016/j.bone.2008.06.015 · Cited by 126
“The frequency of SQSTM1 mediated Paget's disease differs in different populations, but it appears that between 10–50% of patients with familial PDB and between 5–30% of patients with “sporadic” PDB carry mutations in SQSTM1 [13,21,35,52,93].”
BackgroundSelf-citationALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function
Baron, D. M., Fenton, A. R., Saez-Atienzar, S., Giampetruzzi, A., Sreeram, A., Shankaracharya, Keagle, P. J., Doocy, V. R., Smith, N. J., Danielson, E. W., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110598 · Cited by 101
Gennari, L., Rendina, D., Falchetti, A., & Merlotti, D. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00522-3 · Cited by 109
Paget’s disease of bone and genetic disorders of RANKL/OPG/RANK/NF-κB signaling.
WHYTE, M. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.016 · Cited by 95
The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma
Ehrlich, L. A., & Roodman, G. D. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00323.x · Cited by 100
“Patients with truncation mutations in p62 exhibit a more severe Paget’s phenotype than patients with any of the point mutations (32, 35).”
BackgroundLMNA mutation position predicts organ system involvement in laminopathies
Hegele, R. A. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00447.x · Cited by 93
“Sometimes, the mutation type is related to quantitative and/or qualitative differences in phenotype, such as a more severe phenotype associated with nonsense mutations than with missense mutations (4, 5), or variable organ involvement depending on which specific amino acid is substituted (6).”
BackgroundRea, S. L., Walsh, J. P., Ward, L., Yip, K., Ward, B. K., Kent, G. N., Steer, J. H., Xu, J., & Ratajczak, T. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060405 · Cited by 93
“However, our finding that K378X and E396X p62, but not necessarily P392L p62, are functionally more efficient with respect to NF- B activation than the wildtype protein is in agreement with a previous finding that patients with truncation mutations have more extensive bone involvement than patients with missense mutat…”
ResultSelf-citationSQSTM1 splice site mutation in distal myopathy with rimmed vacuoles
Bucelli, R. C., Arhzaouy, K., Pestronk, A., Pittman, S. K., Rojas, L., Sue, C. M., Evilä, A., Hackman, P., Udd, B., Harms, M. B., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001864 · Cited by 92
“Several other SQSTM1 truncation mutations have been reported in patients with familial PDB, including Leu394Ter and Glu396Ter.(26) These truncated species also lack the C-terminal UBA domain but are not generated by cryptic splicing, supporting the hypothesis that SQSTM1DUBA-DK is the pathogenic species.”
BackgroundOsteoclast diseases and dental abnormalities
Helfrich, M. (2005) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2004.11.016 · Cited by 96
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone
Visconti, M. R., Langston, A. L., Alonso, N., Goodman, K., Selby, P. L., Fraser, W. D., & Ralston, S. H. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.132 · Cited by 90
“The PCR methodology was essentially as described previously.((13)) For exon 7, we used the following primers: forward, TTAAAGTCACGCTGGGAACCTGCT, and reverse, AGGGCAGGATGCTCTAAAGGG, and for exon 8, we used the following primers: forward, TCTGGGCAGGCTCGGACACT, and reverse, GTGCTGGGCTGCTAACGTA.”
MethodResultSelf-citationDelayed Development of Paget's Disease in Offspring Inheriting SQSTM1 Mutations
Bolland, M. J., Tong, P. C., Naot, D., Callon, K. E., Wattie, D. J., Gamble, G. D., & Cundy, T. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061204 · Cited by 83
“Paget’s disease develops at an earlier age and is more extensive in families with SQSTM1 mutations than in those without mutations.((6)) SQSTM1 mutations are thought to be highly penetrant((4,7)) and are rare in people without Paget’s disease.”
BackgroundSelf-citationWhitehouse, C. A., Waters, S., Marchbank, K., Horner, A., McGowan, N. W. A., Jovanovic, J. V., Xavier, G. M., Kashima, T. G., Cobourne, M. T., Richards, G. O., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913058107 · Cited by 82
Collet, C., Michou, L., Audran, M., Chasseigneaux, S., Hilliquin, P., Bardin, T., Lemaire, I., Cornélis, F., Launay, J.-M., Orcel, P., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061106 · Cited by 78
SQSTM1 and Paget?s Disease of Bone
Layfield, R., & Hocking, L. J. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0041-0 · Cited by 76
“3%) individuals affected with sporadic PDB [33].”
InfluentialSelf-citationSQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone
Gennari, L., Gianfrancesco, F., Di Stefano, M., Rendina, D., Merlotti, D., Esposito, T., Gallone, S., Fusco, P., Rainero, I., Fenoglio, P., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.31 · Cited by 77
“Consistent with recent observations in two populations of British descent and in the French population, we confirmed that PDB patients with SQSTM1 mutations have a more extensive disease and an earlier age at diagnosis than patients without SQSTM1mutations.((11,17,19)) This observation is in contrast to a previous rep…”
ResultInfluentialCundy, T. (2018) · Metabolism · doi:10.1016/j.metabol.2017.06.010 · Cited by 76
Self-citationCavey, J. R., Ralston, S. H., Sheppard, P. W., Ciani, B., Gallagher, T. R. A., Long, J., Searle, M. S., & Layfield, R. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-1299-6 · Cited by 82
“For the K48-linked polyubiquitin-binding assays of the UBA domain N-terminal deletion constructs, untagged recombinant proteins were prepared as described previously, using thrombin to release the UBA domain polypeptides with an additional GS dipeptide at the N terminus [10].”
BackgroundMethodSelf-citationYip, K. H. M., Feng, H., Pavlos, N. J., Zheng, M., & Xu, J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050960 · Cited by 80
Combined Effects of Exercise and Propranolol on Bone Tissue in Ovariectomized Rats
Bonnet, N., Beaupied, H., Vico, L., Dolleans, E., Laroche, N., Courteix, D., & Benhamou, C.-L. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070117 · Cited by 84
Martini, G., Gennari, L., Merlotti, D., Salvadori, S., Franci, M. B., Campagna, S., Avanzati, A., De Paola, V., Valleggi, F., & Nuti, R. (2007) · Bone · doi:10.1016/j.bone.2006.08.003 · Cited by 72
Genetics of Paget's disease of bone
Daroszewska, A., & Ralston, S. H. (2005) · Clinical Science · doi:10.1042/cs20050053 · Cited by 71
Self-citationRecent advances in understanding the molecular basis of Paget disease of bone
Goode, A., & Layfield, R. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.064428 · Cited by 68
“While not a missense mutation, the Y383X mutation identified in the same study is of interest as this change has been reported to be associated with a higher than average number of skeletal sites,(17) providing support for earlier genotypeephenotype correlations that suggested truncating mutations may be associated wi…”
ResultSelf-citationGenetics and aetiology of Pagetic disorders of bone
Helfrich, M., & Hocking, L. J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.045 · Cited by 77
Self-citationBertrand, M., Petit, V., Jain, A., Amsellem, R., Johansen, T., Larue, L., Codogno, P., & Beau, I. (2015) · Cell Cycle · doi:10.4161/15384101.2014.987619 · Cited by 72
Kwok, C. T., Morris, A. G., & de Belleroche, J. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.184 · Cited by 70
Paget's Disease of Bone: Evidence for Complex Pathogenetic Interactions
Chung, P. Y. J., & Hul, W. V. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.07.005 · Cited by 70
Rea, S. L., Walsh, J. P., Ward, L., Magno, A. L., Ward, B. K., Shaw, B., Layfield, R., Kent, G. N., Xu, J., & Ratajczak, T. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090214 · Cited by 60
Self-citationCundy, T., & Bolland, M. J. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.06.001 · Cited by 65
Self-citationPhase Separation in Regulation of Aggrephagy
Sun, D., Wu, R., Li, P., & Yu, L. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.06.026 · Cited by 55
Albagha, O., Visconti, M. R., Alonso, N., Wani, S., Goodman, K., Fraser, W. D., Gennari, L., Merlotti, D., Gianfrancesco, F., Esposito, T., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1975 · Cited by 64
“Because we and others have previously reported that SQSTM1 mutations influence severity of PDB,((8,12,22)) we looked for evidence of an additive effect of risk allele score and SQSTM1 mutations in predicting disease severity.”
BackgroundMethodInfluentialSelf-citationChung, P. Y. J., Beyens, G., Boonen, S., Papapoulos, S. E., Geusens, P., Karperien, M., Vanhoenacker, F. M. H. M., Verbruggen, L., Fransén, E., Offel, J. V., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0888-2 · Cited by 63
Paget's disease of bone: clinical review and update
Bolland, M. J., & Cundy, T. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201688 · Cited by 63
Self-citationEtiology of Paget's disease and osteoclast abnormalities
Reddy, S. V. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20256 · Cited by 57
“Further studies also identified different mutations affecting the highly conserved ubiquitinbinding domain of SQSTM1/p62 protein in patients with familial and sporadic Paget’s disease [Johnson-Pais et al., 2003; Good et al., 2004; Hocking et al., 2004].”
BackgroundGenetics of Paget’s Disease of Bone
Ralston, S. H., & Albagha, O. (2012) · Elsevier eBooks · doi:10.1007/s11914-014-0219-y · Cited by 62
Self-citationMerchant, A., Smielewska, M., Patel, N., Akunowicz, J. D., Saria, E. A., Delaney, J. D., Leach, R. J., Seton, M., & Hansen, M. F. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081105 · Cited by 54
“(16) Moreover, the polyostotic phenotype and the earlier onset have been correlated to a certain extent with presence of germline nonsense mutations in p62SQSTM1 but not with the missense mutations observed most commonly in patients of familial and sporadic PDB.(30) Thus, the effect of either somatically acquired or i…”
BackgroundInfluentialWalsh, J. P. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb06265.x · Cited by 61
Self-citationHeritable disorders of the RANKL/OPG/RANK signaling pathway.
Whyte, M. P., & Mumm, S. R. (2004) · PubMed · Cited by 58
Update on the pathogenesis and genetics of Paget’s disease of bone
Gennari, L., Rendina, D., Merlotti, D., Cavati, G., Mingiano, C., Cosso, R., Materozzi, M., Pirrotta, F., Abate, V., Calabrese, M., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.932065 · Cited by 60
“, those patients without documented familial clustering) in various patient series (Hocking et al., 2002; Laurin et al., 2002; Johnson-Pais et al., 2003a; Eekhoff et al., 2004; Good et al., 2004; Hocking et al., 2004; Falchetti et al., 2009; Rea et al., 2009; Gennari et al., 2010).”
BackgroundLucas, G., Hocking, L. J., Daroszewska, A., Cundy, T., Nicholson, G. C., Walsh, J. P., Fraser, W. D., Meier, C., Hooper, M. J., & Ralston, S. H. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041106 · Cited by 55
“We identified several mutations affecting the UBA domain of SQSTM1 as previously described,((13,15)) as well as two known polymorphisms in exon 6((12)) at position 916 (C916T/Asp292Asp; refSNP ID rs4935) and 976 (G976A/ TABLE 1.”
BackgroundMethodSelf-citationNajat, D., Garner, T., Hagen, T., Shaw, B., Sheppard, P. W., Falchetti, A., Marini, F., Brandi, M. L., Long, J. E., Cavey, J. R., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081204 · Cited by 50
“coded by this exon resulting in a P387L missense mutation,((5)) two different splice donor site mutations within intron 7,((8,9)) an exon 7 K378X truncating mutation,((10)) and an”
BackgroundSelf-citationAutophagy plays an essential role in bone homeostasis
Jaber, F. A., Khan, N. M., Ansari, M. Y., Al-Adlaan, A. A., Hussein, N. J., & Safadi, F. F. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27071 · Cited by 50
“PDB is known to be a common disorder, which affects approximately 3.1% of people over 55 years old in the United States (Hocking et al., 2004).”
BackgroundInfluentialPaget's disease of bone--becoming a rarity?
Bastin, S., Bird, H., Gamble, G., & Cundy, T. (2009) · Rheumatology · doi:10.1093/rheumatology/kep212 · Cited by 52
Self-citationContribution of Genetic Factors to the Pathogenesis of Paget's Disease of Bone and Related Disorders
Lucas, G., Daroszewska, A., & Ralston, S. H. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s206 · Cited by 53
Self-citationGenetics of Paget’s disease of bone
Michou, L., Collet, C., Laplanche, J., Orcel, P., & Cornélis, F. (2006) · Joint Bone Spine · doi:10.1016/j.jbspin.2005.05.009 · Cited by 55
Lucas, G., Riches, P. L., Hocking, L. J., Cundy, T., Nicholson, G. C., Walsh, J. P., & Ralston, S. H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071004 · Cited by 52
“SQSTM1 (P392L) as a cause of familial PDB in FrenchCanadian families, and we also identified the P392L mutation and other UBA domain mutations of SQSTM1 in 5q35-linked PDB patients of British descent.((23,32)) Subsequently, a large number of investigators identified UBA domain mutations of SQSTM1 in patients with PDB.”
BackgroundSelf-citationOn Behalf of the GenePage Project, Falchetti, A., Stefano, M. D., Marini, F., Ortolani, S., Ulivieri, F. M., Bergui, S., Masi, L., Cepollaro, C., Benucci, M., et al. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9192-8 · Cited by 53
“frequencies, our study confirmed previously published data from other groups [7, 10, 11, 13, 14, 16, 23, 24].”
BackgroundResultInfluentialClinical and Genetic Advances in Paget’s Disease of Bone: a Review
Alonso, N., Calero‐Paniagua, I., & del Pino‐Montes, J. (2016) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-016-9226-0 · Cited by 53
“Several other hotspots have been identified in the protein, mainly in the UBA domain [58–61].”
BackgroundInfluentialWhyte, M. P., Singhellakis, P. N., Petersen, M. B., Davies, M., Totty, W. G., & Mumm, S. R. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070307 · Cited by 42
“sults from heterozygous, domain-specific, loss-of-function mutations in SQSTM1 encoding sequestosome-1,((31)) including relatively severe PDB phenotypes,((32)) SQSTM1 de-”
BackgroundChung, P. Y. J., Beyens, G., Riches, P. L., Wesenbeeck, L. V., de Freitas, F., Jennes, K., Daroszewska, A., Fransén, E., Boonen, S., Geusens, P., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.162 · Cited by 53
Self-citationMechanisms of Disease: genetics of Paget's disease of bone and related disorders
Daroszewska, A., & Ralston, S. H. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0172 · Cited by 44
“Since these initial reports, a total of 11 different SQSTM1 mutations have been identified in familial PDB, all of which cluster in or around the ubiquitin-associated domain of the protein product of this gene ( Table 2 )”
Self-citationAnalysis of neurodegenerative disease-causing genes in dementia with Lewy bodies
Orme, T., Hernandez, D., Ross, O. A., Kun-Rodrigues, C., Darwent, L., Shepherd, C. E., Parkkinen, L., Ansorge, O., Clark, L., Honig, L. S., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-0879-z · Cited by 41
“00001591 3 (113732) Several families with Paget’s disease of bone Variant shown to cause Paget’s disease of bone (not FTD-ALS) [23, 30]”
Layfield, R., Ciani, B., Ralston, S. H., Hocking, L. J., Sheppard, P. W., Searle, M. S., & Cavey, J. R. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320728 · Cited by 47
Self-citationChung, P. Y. J., Beyens, G., Guañabens, N., Boonen, S., Papapoulos, S. E., Karperien, M., Eekhoff, E. M. W., Wesenbeeck, L. V., Jennes, K., Geusens, P., et al. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9137-2 · Cited by 44
“Several authors have observed that patients with a truncated SQSTM1 protein had a more severe phenotype than patients carrying a missense mutation [14, 29 , 40, 42].”
BackgroundLucas, G., Mehta, S. G., Hocking, L. J., Stewart, T. L., Cundy, T., Nicholson, G. C., Walsh, J. P., Fraser, W. D., Watts, G. D. J., Ralston, S. H., et al. (2005) · Bone · doi:10.1016/j.bone.2005.07.014 · Cited by 45
Self-citationThe molecular pathogenesis of Paget disease of bone
Layfield, R. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000464 · Cited by 39
Self-citationRea, S., & Foster, A. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.284977 · Cited by 37
“The role of p62 in this pathway has mainly been characterized with respect to mutations that cause PDB, a chronic and progressive skeletal disorder that involves increased osteoclastic bone resorption and deposition, leading to focal lesions of increased bone turnover.”
BackgroundInfluentialWeakly and strongly associated nonfreezable water bound in bones
Turov, V. V., Гунько, В. М., Zarko, V. I., Leboda, R., Jabłoński, M., Gorzelak, M., & Jagiełło-Wójtowicz, E. (2006) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2006.02.001 · Cited by 38
Cundy, T., & Reid, I. R. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.09.026 · Cited by 45
Self-citationEpidemiogenetic study of French families with Paget's disease of bone
Michou, L., Collet, C., Morissette, J., Audran, M., Thomas, T., Gagnon, É., Launay, J., Laplanche, J., Brown, J. P., & Orcel, P. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.07.005 · Cited by 39
Al-Rashid, M., Ramkumar, D. B., Raskin, K. A., Schwab, J. H., Hornicek, F. J., & Lozano‐Calderón, S. A. (2015) · Orthopedic Clinics of North America · doi:10.1016/j.ocl.2015.06.008 · Cited by 39
Goode, A., Long, J., Shaw, B., Ralston, S. H., Visconti, M. R., Gianfrancesco, F., Esposito, T., Gennari, L., Merlotti, D., Rendina, D., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.03.006 · Cited by 37
Self-citationMichou, L., Morissette, J., Gagnon, É., Marquis, A., Dellabadia, M., Brown, J. P., & Siris, E. S. (2010) · Bone · doi:10.1016/j.bone.2010.11.004 · Cited by 34
“Although studies investigating genotype–phenotype correlations in PDB may have been underpowered, pagetic patient carriers of a SQSTM1 mutation may have an earlier age at PDB diagnosis and a higher number of affected bones when compared to PDB patients with a nonmutated SQSTM1 gene [12,14,18,19].”
ResultEvolution of Paget's disease of bone in adults inheriting SQSTM 1 mutations
Cundy, T., Rutland, M. D., Naot, D., & Bolland, M. J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12741 · Cited by 35
Self-citationImpact of p62/SQSTM1 UBA Domain Mutations Linked to Paget’s Disease of Bone on Ubiquitin Recognition
Garner, T. P., Long, J., Layfield, R., & Searle, M. S. (2011) · Biochemistry · doi:10.1021/bi200079n · Cited by 32
Self-citationClinical and Cellular Phenotypes Associated With Sequestosome 1 (SQSTM1) Mutations
Leach, R. J., Singer, F. R., Ench, Y., Wisdom, J. H., Pina, D. S., & Johnson-Pais, T. L. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.06s208 · Cited by 29
“They also concluded that kindreds with SQSTM1 mutations had an earlier age of diagnosis on average than familial Paget’s disease kindreds without SQSTM1 mutations.((16)) Based on the intrafamilial expressivity observed in our largest kindreds, it would be difficult to make a similar conclusion.”
BackgroundInfluentialA review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg
Abelson, A. G. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x260899 · Cited by 28
Chung, P. Y. J., Beyens, G., de Freitas, F., Boonen, S., Geusens, P., Vanhoenacker, F. M. H. M., Verbruggen, L., Offel, J. V., Goemaere, S., Zmierczak, H., et al. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.03.021 · Cited by 34
Zach, F., Polzer, F., Mueller, A., & Gessner, A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002449 · Cited by 31
p62 mutations, ubiquitin recognition and Paget's disease of bone
Layfield, R., Cavey, J. R., Najat, D., Long, J., Sheppard, P. W., Ralston, S. H., & Searle, M. S. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340735 · Cited by 33
Self-citationUpdates on Paget’s Disease of Bone
Choi, Y. J., Sohn, Y. B., & Chung, Y. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1575 · Cited by 32
“SQSTM1 mutation carriers tend to develop the disease at an earlier age and have more extensive illness [45].”
BackgroundRendina, D., Falchetti, A., Diacinti, D., Bertoldo, F., Merlotti, D., Giannini, S., Cianferotti, L., Girasole, G., Monaco, M. D., Gonnelli, S., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02318-1 · Cited by 29
USP8 prevents aberrant NF-κB and Nrf2 activation by counteracting ubiquitin signals from endosomes
Endo, A., Fukushima, T., Takahashi, C., Tsuchiya, H., Ohtake, F., Ono, S., Ly, T., Yoshida, Y., Tanaka, K., Saeki, Y., et al. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202306013 · Cited by 25
“We then generated cells stably expressing FLAG-tagged p62 as well as mutants lacking ubiquitin-binding ability, dUBA and VVV (substitution of 404 MGF 406 in the UBA domain with VVV; Hocking et al., 2004; Seibenhener et al., 2004; Fig.”
The Changing Presentation of Paget’s Disease of Bone in Australia, A High Prevalence Region
Britton, C., Brown, S. J., Ward, L., Rea, S. L., Ratajczak, T., & Walsh, J. P. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0312-1 · Cited by 25
Self-citationFalchetti, A., Masi, L., & Brandi, M. L. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833af61e · Cited by 26
Cronin, O., Forsyth, L., Goodman, K., Lewis, S. C., Keerie, C., Walker, A., Porteous, M. E., Cetnarskyj, R., Ranganath, L. R., Selby, P. L., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-030689 · Cited by 25
Self-citationUbiquitin-mediated signalling and Paget's disease of bone
Layfield, R., & Shaw, B. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s5 · Cited by 26
“These mutations include five truncating mutations that delete most or all of the UBA domain, and seven missense mutations located within the UBA domain [22,25-30].”
BackgroundSelf-citationThe changing countenance of Paget's Disease of bone
Michou, L., & Orcel, P. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2016.02.011 · Cited by 23
Nagy, Z. B., Gergely, P., Donáth, J., Borgulya, G., Csanád, M., & Poór, G. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.071021 · Cited by 26
“The ifn, ifn- , and ifn- cooperate in the elimination of virus.((34)) We detected significant upregulation of ifn- ifn-”
BackgroundBeyens, G., Wuyts, W. A., Cleiren, E., de Freitas, F., Tiegs, R. D., & Hul, W. V. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0122-3 · Cited by 23
Detection of SQSTM1/P392L post-zygotic mutations in Paget’s disease of bone
Guay-Bélanger, S., Picard, S., Gagnon, É., Morissette, J., Siris, E. S., Orcel, P., Brown, J. P., & Michou, L. (2014) · Human Genetics · doi:10.1007/s00439-014-1488-3 · Cited by 23
“2010), and similar frequencies were also observed in United Kingdom and New Zealand (Cundy et al. 2011; Hocking et al. 2004).”
ResultInfluentialCorral-Gudino, L., del Pino‐Montes, J., García‐Aparicio, J., Corral, E., Montilla, C. A., & González‐Sarmiento, R. (2005) · Bone · doi:10.1016/j.bone.2005.09.010 · Cited by 22
“Recently, mutations in the sequestosome (SQSTM1/p62) gene have been identified in familial PBD, as well as in 5–15% of patients with no family history [26–28].”
BackgroundFalchetti, A., Stefano, M. D., Marini, F., Monte, F. D., Gozzini, A., Masi, L., Tanini, A., Amedei, A., Carossino, A., Isaia, G., et al. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1828 · Cited by 20
“R1290 confirmed in other ethnic groups [7-9].”
BackgroundInfluentialReprint: Paget's disease of bone
Cundy, T., & Reid, I. R. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.06.011 · Cited by 20
Self-citation
Metadata
- Authors
- Hocking, L. J., Lucas, G. J., Daroszewska, A., Cundy, T., Nicholson, G. C., Donath, J., Walsh, J. P., Finlayson, C., Cavey, J. R., Ciani, B., Sheppard, P. W., Searle, M. S., Layfield, R., & Ralston, S. H.
- Affiliations
- University of Aberdeen (GB)
- University of Auckland (NZ)
- Department of Clinical and Biomedical Sciences, Barwon Health, Geelong Hospital, University of Melbourne, Melbourne, Australia
- National Institute of Rheumatology, Budapest, Hungary
- Sir Charles Gairdner Hospital (AU)
- University of Nottingham (GB)
- Affiniti Research Products, Exeter, United Kingdom
- Corresponding author
- Ralston, Stuart H
- ORCID
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-07-01
- Volume
- 19
- Issue
- 7
- Pages
- 1122-1127
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2016415830
- Cited by
- 156
- References
- 19
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 7 · 2014: 6 · 2013: 5 · 2012: 9
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (University of Western Australia) (submittedVersion)
- Funders
- University of Aberdeen
- Medical Research Council
- Engineering and Physical Sciences Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone Tumor Diagnosis and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Paget's disease of bone, p62, UBA domain, missense mutations, genotype-phenotype correlation, protein structure, truncating mutations, disease severity, kindred, mutation detection, NMR structural analysis, functional analysis of mutations, premature stop codon
- MeSH terms
- Sequestosome-1 Protein, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Osteitis Deformans, Phenotype, Proteins, Protein Structure, Tertiary, Nuclear Magnetic Resonance, Biomolecular, Mutation, Missense, Ubiquitin, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.